Skip to content

Biodesix, Inc. BDSX Other Financing

Other Financing at other companies

Guardant Health logo
Guardant HealthGH
-$4.48M-149,100%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$84M-37.7%
CareDx logo
CareDxCDNA
$1.5M0.0%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s other financing?
Biodesix, Inc. (BDSX) reported other financing of -$158K in Q1 2026.
How has Biodesix, Inc.'s other financing changed year-over-year?
Biodesix, Inc.'s other financing increased by 20.2% year-over-year, from -$198K to -$158K.
What is the long-term trend for Biodesix, Inc.'s other financing?
Over 3 years (2022 to 2025), Biodesix, Inc.'s other financing has grown at a -57.7% compound annual growth rate (CAGR), from $10.82M to -$817K.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.